Literature DB >> 2004486

Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63).

S C Mendonça1, D G Russell, S G Coutinho.   

Abstract

The responsiveness of peripheral blood lymphocytes from 15 cutaneous leishmaniasis patients and five healthy volunteers to purified surface antigens of Leishmania was studied. The following purified antigens were independently used as stimuli for lymphocyte proliferation in vitro: lipophosphoglycan of L. braziliensis, (Lb-LPG), lipophosphoglycan of L. mexicana (Lm-LPG), glycoprotein 63 of L. braziliensis (Lb-gp 63) and glycoprotein 63 of L. mexicana (Lm-gp 63). Among six patients tested with Lb-gp 63 and Lm-gp 63, two borderline responses and two positive responses were observed, respectively, all the others being negative. Lb-LPG and Lm-LPG induced positive responses in all patients tested (11 with Lb-LPG and five with Lm-LPG). A positive dose-response correlation was observed in the responses of the patients to both Lb-LPG and Lm-LPG. Significant differences (P less than 0.01) were found between the two groups (patients and healthy subjects) with regard to the responses to Lb-LPG. The proliferating cells after stimulation with Lb-LPG were shown to belong to the CD4+ T cell subset by flow cytometry. However, the following evidence suggests that the T cell responses were not induced by LPG itself but rather by protein contaminants in the LPG preparations: a highly purified Lb-LPG batch that had undergone additional purification induced positive responses in cells from only three out of six patients and a proteinase K-treated Lb-LPG batch did not stimulate any positive response among the same six patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004486      PMCID: PMC1535308          DOI: 10.1111/j.1365-2249.1991.tb05663.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Quantitative study of Leishmania braziliensis braziliensis reactive T cells in peripheral blood and in the lesions of patients with American mucocutaneous leishmaniasis.

Authors:  F Conceição-Silva; R C Dórea; C Pirmez; A Schubach; S G Coutinho
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

2.  Genes encoding the major surface glycoprotein in Leishmania are tandemly linked at a single chromosomal locus and are constitutively transcribed.

Authors:  L L Button; D G Russell; H L Klein; E Medina-Acosta; R E Karess; W R McMaster
Journal:  Mol Biochem Parasitol       Date:  1989-01-15       Impact factor: 1.759

3.  Cloning of a major developmentally regulated gene expressed in mature females of Schistosoma mansoni.

Authors:  A J Simpson; M Knight
Journal:  Mol Biochem Parasitol       Date:  1986-01       Impact factor: 1.759

4.  Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica.

Authors:  P M Preston; R L Carter; E Leuchars; A J Davies; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

5.  Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease.

Authors:  A D Bryceson
Journal:  Trans R Soc Trop Med Hyg       Date:  1969       Impact factor: 2.184

6.  Action of leishmanial excreted factor (EF) on human lymphocyte blast transformation.

Authors:  M V Londner; S Frankenburg; G M Slutzky; C L Greenblatt
Journal:  Parasite Immunol       Date:  1983-05       Impact factor: 2.280

7.  A histological classification of cutaneous leishmaniasis and its geographical expression.

Authors:  D S Ridley
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

8.  Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig.

Authors:  A D Bryceson; P M Preston; R S Bray; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

9.  Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major.

Authors:  H Moll; G F Mitchell; M J McConville; E Handman
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

10.  Monoclonal antibodies to Leishmania tropica major: specificities and antigen location.

Authors:  A A de Ibarra; J G Howard; D Snary
Journal:  Parasitology       Date:  1982-12       Impact factor: 3.234

View more
  14 in total

1.  UDP-Gal: N-acetylglucosamine beta 1-4 galactosyltransferase expressing live attenuated parasites as vaccine for visceral leishmaniasis.

Authors:  Siddhartha Kumar Bhaumik; Manoj Kumar Singh; Subir Karmakar; Tripti De
Journal:  Glycoconj J       Date:  2008-11-13       Impact factor: 2.916

2.  Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.

Authors:  Marie Breton; Michel J Tremblay; Marc Ouellette; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 3.  Leishmaniasis: current status of vaccine development.

Authors:  E Handman
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

4.  Glycosphingolipid antigens of Leishmania (Leishmania) amazonensis amastigotes identified by use of a monoclonal antibody.

Authors:  C L Barbiéri; S Giorgio; A J Merjan; E N Figueiredo
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 5.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L. amazonensis in natural infection versus immunization.

Authors:  R B G Azeredo-Coutinho; D C S Matos; G G R Armôa; R M Maia; A Schubach; W Mayrink; S C F Mendonça
Journal:  Clin Exp Immunol       Date:  2008-07-08       Impact factor: 4.330

7.  Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals.

Authors:  M Kemp; M B Hansen; T G Theander
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation.

Authors:  D L Tolson; A Jardim; L F Schnur; C Stebeck; C Tuckey; R P Beecroft; H S Teh; R W Olafson; T W Pearson
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.

Authors:  M E Wilson; B M Young; K P Andersen; J V Weinstock; A Metwali; K M Ali; J E Donelson
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein.

Authors:  A Jardim; V Funk; R M Caprioli; R W Olafson
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.